Skip to content
User

Parnassus Endeavor Fund ABT trades

Parnassus Investments

Parnassus Endeavor Fund Abbott Laboratories stake

total: 120

Trades details

Total transactions:
5
New positions:
1
Added:
4
Held since:
2025 Q3
Held for:
5 quarters
Latest activity:
2026 Q3
According to 2026 Q3 report, Parnassus Endeavor Fund holds 784,786 Abbott Laboratories (ABT) shares with a market value of roughly $77.56M accounting for 1.52% of the overall portfolio. To date, the estimated cost basis is nearly $125.34 for "buy" trades. Parnassus Endeavor Fund first purchased ABT in 2025 Q3, initially acquiring 524,454 shares. Since the initial investment in Abbott Laboratories (ABT), Parnassus Endeavor Fund has made 4 more transactions.

How many ABT shares does Parnassus Endeavor Fund currently hold?

According to 2026 Q3 report, Parnassus Endeavor Fund holds 784,786 shares of Abbott Laboratories (ABT), valued at around $77.56M.

When did Parnassus Endeavor Fund buy Abbott Laboratories (ABT)?

Parnassus Endeavor Fund first invested in Abbott Laboratories (ABT) in 2025 Q3 at the reported quarter-end price of $133.94 per share.

What's the cost basis of Parnassus Endeavor Fund's ABT stake?

The estimated cost basis for Abbott Laboratories (ABT) stake is around $125.34 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$125.34

Parnassus Endeavor Fund's historical trades in Abbott Laboratories

5 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
1.52%
784,786
$98.83
$77,560,400
+21.63% (+139,559)
+0.27%
2026 Q2
1.11%
645,227
$90.74
$58,547,898
+1.41% (+8,980)
+0.02%
2026 Q1
1.41%
636,247
$102.67
$65,323,479
+3.56% (+21,848)
+0.05%
2025 Q4
1.62%
614,399
$125.29
$76,978,051
+17.15% (+89,945)
+0.24%
2025 Q3
1.49%
524,454
$133.94
$70,245,369
new
+1.49%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.